Home About Us Industry Report Store Resources Contact us

Targeted Drug Delivery Market Growth Analysis Research Report segmented by Disease Type (Pulmonary Diseases, Endocrine Diseases, Cardiovascular Diseases, Infectious Diseases, and Oncological Disorders), By Application (First Order Targeting [Organ Compartmentalization], Second Order Targeting [Cellular Targeting], and Third Order Targeting [Intracellular Targeting]), By End User (Hospitals, Clinics, and Others), and Regional Forecast till 2030

5/5
( 14 votes )

Categories: Pharma & Healthcare

Format :

  1. Market Dynamics, Regulations, and Trends Analysis
    1. Drivers
    2. Restraints
    3. Market Opportunities
    4. Market Dynamics
    5. Impact Analysis
    6. Pipeline Analysis
    7. PEST Analysis
    8. Regulatory Scenario
    9. Market Trends
    10. Key Highlights
    11. Mergers & Acquisitions
  2. Global Targeted Drug Delivery Market – Impact of Coronavirus (COVID-19) Pandemic
    1. Economic Impact
    2. Impact on Clinical Trials
    3. Government Initiatives
  3. Global Targeted Drug Delivery Market, By Disease Type, 2023 – 2030, (US$ Million)
    1. Market Share Analysis, 2022 and 2030 (%)
    2. Y-o-Y Growth Analysis, 2023 – 2030
    3. Segment Trends
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    3. Introduction
    4. Cardiovascular Diseases
    5. Pulmonary Diseases
    6. Infectious Diseases
    7. Endocrine Diseases
    8. Oncological Disorders
  4. Global Targeted Drug Delivery Market, By Application, 2023 – 2030, (US$ Million)
    1. Market Share Analysis, 2022 and 2030 (%)
    2. Y-o-Y Growth Analysis, 2023 – 2030
    3. Segment Trends
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    3. Introduction
    4. First Order Targeting (Organ Compartmentalization)
    5. Second Order Targeting (Cellular Targeting)
    6. Third Order Targeting (Intracellular Targeting)
  5. Global Targeted Drug Delivery Market, By End User, 2023 – 2030, (US$ Million)
    1. Market Share Analysis, 2022 and 2030 (%)
    2. Y-o-Y Growth Analysis, 2023 – 2030
    3. Segment Trends
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    1. Introduction
    2. Market Size and Forecast, and Y-o-Y Growth, 2023 – 2030, (US$ Mn)
    3. Introduction
    4. Hospitals
    5. Clinics
    6. Others
  6. Global Targeted Drug Delivery Market, By Region, 2023 – 2030, (US$ Million)
    1. Market Share Analysis, By Region, 2022 and 2030 (%)
    2. Y-o-Y Growth Analysis, For Regions, 2023–2030
    1. Market Size and Forecast, By Disease Type, 2023 – 2030, (US$ Mn)
    2. Market Size and Forecast, By Application, 2023 – 2030, (US$ Mn)
    3. Market Size and Forecast, By End User, 2023 – 2030, (US$ Mn)
    4. Market Size and Forecast, By Country, 2023 – 2030, (US$ Mn)
      1. U.S.
      2. Canada
    1. Market Size and Forecast, By Disease Type, 2023 – 2030, (US$ Mn)
    2. Market Size and Forecast, By Application, 2023 – 2030, (US$ Mn)
    3. Market Size and Forecast, By End User, 2023 – 2030, (US$ Mn)
    4. Market Size and Forecast, By Country, 2023 – 2030, (US$ Mn)
      1. Brazil
      2. Mexico
      3. Argentina
      4. Rest of Latin America
    1. Market Size and Forecast, By Disease Type, 2023 – 2030, (US$ Mn)
    2. Market Size and Forecast, By Application, 2023 – 2030, (US$ Mn)
    3. Market Size and Forecast, By End User, 2023 – 2030, (US$ Mn)
    4. Market Size and Forecast, By Country, 2023 – 2030, (US$ Mn)
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    1. Market Size and Forecast, By Disease Type, 2023 – 2030, (US$ Mn)
    2. Market Size and Forecast, By Application, 2023 – 2030, (US$ Mn)
    3. Market Size and Forecast, By End User, 2023 – 2030, (US$ Mn)
    4. Market Size and Forecast, By Country, 2023 – 2030, (US$ Mn)
      1. China
      2. India
      3. Japan
      4. Australia
      5. South Korea
      6. ASEAN
      7. Rest of Asia Pacific
    1. Market Size and Forecast, By Disease Type, 2023 – 2030, (US$ Mn)
    2. Market Size and Forecast, By Application, 2023 – 2030, (US$ Mn)
    3. Market Size and Forecast, By End User, 2023 – 2030, (US$ Mn)
    4. Market Size and Forecast, By Country, 2023 – 2030, (US$ Mn)
      1. GCC
      2. Israel
      3. Rest of Middle East
    1. Market Size and Forecast, By Disease Type, 2023 – 2030, (US$ Mn)
    2. Market Size and Forecast, By Application, 2023 – 2030, (US$ Mn)
    3. Market Size and Forecast, By End User, 2023 – 2030, (US$ Mn)
    4. Market Size and Forecast, By Country, 2023 – 2030, (US$ Mn)
      1. South Africa
      2. Central Africa
      3. North Africa
    5. Introduction
    6. North America
    7. Latin America
    8. Europe
    9. Asia Pacific
    10. Middle East
    11. Africa
  7. Competitive Landscape
    1. AbbVie Inc.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    2. Ablynx NV by Sanofi SA
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    3. Arrowhead Pharmaceuticals, Inc.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    4. Baxter International Inc.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    5. AstraZeneca PLC
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    6. Boston Scientific Corporation
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    7. Becton
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    8. Depomed, Inc.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    9. Fraunhofer Gesellschaft Munchen
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    10. Janssen Global Services, LLC
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    11. Luye Pharma Group
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    12. Pfizer Inc.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    13. Quark Pharmaceuticals Inc.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    14. Rexahn Pharmaceuticals Inc.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    15. Savara Inc.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    16. Roche Holding AG
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    17. Suda Limited
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    18. Vectura Group PLC
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    19. Taiwan Liposome Company, Ltd.
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    20. 3M
      1. Company Overview
      2. Product Portfolio
      3. Financial Overview
      4. Key Highlights
      5. Market Strategies
    21. Heat Map Analysis
    22. Market Share Analysis
    23. Analyst Views
  8. Section
    1. References
    2. Research Methodology
    3. About us and Sales Contact

Select Licence Type


Single User

US$ 2499


Multi User

US$ 3499


Corporate User

US$ 4499

Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 2499

Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 3499

The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.

US $ 4499

Need a Discount? Get in touch with us for special pricing

Connect with our sales team

Phone:

Toll Free:

Email: sales@marketreportservice.com